ArticleSleep & breathing = Schlaf & Atmung2020

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced bone metabolism disorder and destruction in rats.

Zhan-Jun Dou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.